To further confirm if the inhibition of TGF-β signal without the activation of p53 plays a key role in heteronemin-induced anti-proliferation in cholangiocarcinoma, knockdown studies of TGF-β and p53 were conducted. This evidence concerns the gene TP53 and cholangiocarcinoma.